EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOMYG00000020106
Gene Symbol: AVPR1A
1 Cross references
139 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOMYG00000056944
Gene Symbol: AVPR1A
1 Cross references
139 Possible Orthologues:

Aryl Hydrocarbon Receptor 1a

Ensembl ID : ENSOMYG00000036618
Gene Symbol: AHR1A
1 Cross references
152 Possible Orthologues:

Aryl Hydrocarbon Receptor 1a

Ensembl ID : ENSOMYG00000001067
Gene Symbol: AHR1A
1 Cross references
152 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSOMYG00000009571
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSOMYG00000046516
Gene Symbol: BACE1
1 Cross references
212 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSOMYG00000031140
Gene Symbol: BACE1
1 Cross references
212 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSOMYG00000041617
Gene Symbol: BDKRB1
1 Cross references
141 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSOMYG00000042797
Gene Symbol: BDKRB1
2 Cross references
144 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSOMYG00000052151
Gene Symbol: CACNA1C
1 Cross references
212 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSOMYG00000057033
Gene Symbol: CACNA1C
1 Cross references
212 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSOMYG00000002904
Gene Symbol: CACNA1DA
1 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).